Design, synthesis and biological evaluation of imidazo [2, 1-b] thiazole and benzo [d] imidazo [2, 1-b] thiazole derivatives as Mycobacterium tuberculosis pantothenate … G Samala, PB Devi, S Saxena, N Meda, P Yogeeswari, D Sriram Bioorganic & medicinal chemistry 24 (6), 1298-1307, 2016 | 61 | 2016 |
Development of 3-phenyl-4, 5, 6, 7-tetrahydro-1H-pyrazolo [4, 3-c] pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors G Samala, PB Devi, R Nallangi, P Yogeeswari, D Sriram European journal of medicinal chemistry 69, 356-364, 2013 | 47 | 2013 |
Development of novel tetrahydrothieno [2, 3-c] pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known … G Samala, PB Devi, R Nallangi, JP Sridevi, S Saxena, P Yogeeswari, ... Bioorganic & medicinal chemistry 22 (6), 1938-1947, 2014 | 46 | 2014 |
Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening S Saxena, PB Devi, V Soni, P Yogeeswari, D Sriram Journal of Molecular Graphics and Modelling 47, 37-43, 2014 | 42 | 2014 |
Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors S Saxena, G Samala, JP Sridevi, PB Devi, P Yogeeswari, D Sriram European Journal of Medicinal Chemistry 92, 401-414, 2015 | 35 | 2015 |
Identification and development of 2-methylimidazo [1, 2-a] pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors G Samala, R Nallangi, PB Devi, S Saxena, R Yadav, JP Sridevi, ... Bioorganic & Medicinal Chemistry 22 (15), 4223-4232, 2014 | 35 | 2014 |
A review on DNA nanobots: A new techniques for cancer treatment U Devasena, P Brindha, R Thiruchelvi Asian J Pharm Clin Res 11 (6), 61-4, 2018 | 32 | 2018 |
Structure‐Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors PB Devi, G Samala, JP Sridevi, S Saxena, M Alvala, EG Salina, D Sriram, ... ChemMedChem 9 (11), 2538-2547, 2014 | 31 | 2014 |
Development of 2-(4-oxoquinazolin-3 (4H)-yl) acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis GS Pedgaonkar, JP Sridevi, VU Jeankumar, S Saxena, PB Devi, ... European journal of medicinal chemistry 86, 613-627, 2014 | 29 | 2014 |
Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus R Janupally, VU Jeankumar, KA Bobesh, V Soni, PB Devi, VK Pulla, ... Bioorganic & Medicinal Chemistry 22 (21), 5970-5987, 2014 | 28 | 2014 |
Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities PB Devi, S Jogula, AP Reddy, S Saxena, JP Sridevi, D Sriram, ... Molecular Informatics 34 (2‐3), 147-159, 2015 | 17 | 2015 |
Development of benzo [d] oxazol-2 (3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA GS Pedgaonkar, JP Sridevi, VU Jeankumar, S Saxena, PB Devi, ... Bioorganic & medicinal chemistry 22 (21), 6134-6145, 2014 | 17 | 2014 |
Design and Biological Evaluation of Furan/Pyrrole/Thiophene‐2‐carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureus R Janupally, B Medepi, P Brindha Devi, P Suryadevara, VU Jeankumar, ... Chemical Biology & Drug Design 86 (4), 918-925, 2015 | 16 | 2015 |
Discovery of novel lysine ɛ-aminotransferase inhibitors: an intriguing potential target for latent tuberculosis PB Devi, JP Sridevi, SS Kakan, S Saxena, VU Jeankumar, V Soni, ... Tuberculosis 95 (6), 786-794, 2015 | 15 | 2015 |
COVID-19—In silico structure prediction and molecular docking studies with doxycycline and quinine A Sumitha, PB Devi, S Hari, R Dhanasekaran Biomed. Pharmacol. J 13, 1185-1193, 2020 | 11 | 2020 |
Computational sampling and simulation based assessment of novel Mycobacterium tuberculosis glutamine synthetase inhibitors: Study involving structure based drug design and free … P Suryadevara, P Yogeeswari, V Soni, P Brindha Devi, ... Current topics in medicinal chemistry 16 (9), 978-995, 2016 | 11 | 2016 |
Anti-tubercular activities of 5, 6, 7, 8-tetrahydrobenzo [4, 5] thieno [2, 3-d] pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium … G Samala, PB Devi, S Saxena, S Gunda, P Yogeeswari, D Sriram Bioorganic & medicinal chemistry 24 (21), 5556-5564, 2016 | 10 | 2016 |
Pharmacophoric Screening of Various Endophytic Fungal Metabolites EE Brindha Devi P, Rajagopal K Asian Journal of Pharmaceutical and Clinical Research 10 (5), 2017 | 9* | 2017 |
Docking Studies for Various Antibacterial Benzilate Derivatives NG Sudha R, Brindha Devi P, Charles C Kanakam Asian Journal of Pharmaceutical and Clinical Research 10 (4), 2017 | 9* | 2017 |
Docking Antioxidant Activity On Hydroxy (Diphenyl) Acetic acid And Its Derivatives CCK Sudha Rajendran, Nithya G, Brindha Devi P Asian Journal of Pharmaceutical and Clinical Research 10 (7), 2017 | 8* | 2017 |